Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Systematic review and meta-analysis concludes immunofixation (SIFE and UIFE) and sFLC ratio combined give sensitivity of 0.99 (0.96-1.00)) as reliable initial testing strategy to raise suspicion of diagnosis of AL amyloidosis.”
Title: Diagnostic Utility of Immunofixation and Free Light Chain Assay in AL Amyloidosis: A Systematic Review and Meta-analysis
Authors: Muayad Azzam, Qais Hamarsha, Hassan Kawtharany, Jamil Nazzal, Aseel Alkhader, Tala Khraise, Mohammad M AlMasri, Hadi K. Abou Zeid, Iktimal Alwan, Nour Jaber, Matthew D Seftel, Maria Adela Aguirre, Deborah Boedicker, Naresh Bumma, Antonia S. Carroll, Raymond Comenzo, Joselle Cook, Noel R Dasgupta, Alfredo De La Torre, Angela Dispenzieri, Faizi Jamal, Jack Khouri, Maria M Picken, Shahzad Raza, Nelson Leung, Vaishali Sanchorawala, Nitasha Sarswat, Hira Shaikh, Daulath Singh, Vishal Kukreti, Reem A. Mustafa
You can read the Full Article in Blood Advances.
You can find other articles featuring Robert Orlowski on OncoDaily.
